98 related articles for article (PubMed ID: 16453002)
1. Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.
Nückel H; Frey UH; Sellmann L; Bau M; Dürig J; Dührsen U; Siffert W
Leukemia; 2006 Apr; 20(4):724. PubMed ID: 16453002
[No Abstract] [Full Text] [Related]
2. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
3. The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
Leukemia; 2006 Jan; 20(1):77-81. PubMed ID: 16307023
[TBL] [Abstract][Full Text] [Related]
4. The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukemia.
Fegan C; Starczynski J; Pratt G; Pepper C
Leukemia; 2006 Aug; 20(8):1460-1. PubMed ID: 16761015
[No Abstract] [Full Text] [Related]
5. The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia.
Kaderi MA; Norberg M; Murray F; Merup M; Sundström C; Roos G; Aleskog A; Karlsson K; Axelsson T; Tobin G; Rosenquist R
Leukemia; 2008 Feb; 22(2):339-43. PubMed ID: 18046447
[TBL] [Abstract][Full Text] [Related]
6. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Dicker F; Rauhut S; Kohlmann A; Kern W; Schoch C; Haferlach T; Schnittger S
J Natl Cancer Inst; 2005 Jul; 97(14):1092-3; author reply 1093-5. PubMed ID: 16030312
[No Abstract] [Full Text] [Related]
7. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Nenning UC; Eckert C; Wellmann S; Barth A; Henze G; Seeger K
J Natl Cancer Inst; 2005 Jul; 97(14):1091-2; author reply 1093-5. PubMed ID: 16030311
[No Abstract] [Full Text] [Related]
8. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia.
Riemann K; Becker L; Struwe H; Nückel H; Dührsen U; Alakus H; Winde G; Neuhäuser M; Rübben H; Schmitz KJ; Wohlschlaeger J; Schmid KW; Siffert W
Pharmacogenet Genomics; 2006 Nov; 16(11):783-8. PubMed ID: 17047486
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia.
Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
Leukemia; 2004 Nov; 18(11):1816-23. PubMed ID: 15385937
[TBL] [Abstract][Full Text] [Related]
10. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Iglesias-Serret D; Coll-Mulet L; Santidrián AF; Navarro-Sabaté A; Domingo A; Pons G; Gil J
J Natl Cancer Inst; 2005 Jul; 97(14):1090-1; author reply 1093-5. PubMed ID: 16030310
[No Abstract] [Full Text] [Related]
11. G125A single-nucleotide polymorphism in the human BAX promoter affects gene expression.
Moshynska O; Moshynskyy I; Misra V; Saxena A
Oncogene; 2005 Mar; 24(12):2042-9. PubMed ID: 15688029
[TBL] [Abstract][Full Text] [Related]
12. Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.
Tobin G; Skogsberg A; Thunberg U; Laurell A; Aleskog A; Merup M; Sundström C; Roos G; Nilsson K; Rosenquist R
Leukemia; 2005 May; 19(5):871-3. PubMed ID: 15759030
[No Abstract] [Full Text] [Related]
13. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
[TBL] [Abstract][Full Text] [Related]
14. Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia.
Hauswirth AW; Jäger U
Haematologica; 2008 Jan; 93(1):14-9. PubMed ID: 18166780
[No Abstract] [Full Text] [Related]
15. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Pérez-Chacón G; Contreras-Martín B; Cuní S; Rosado S; Martín-Donaire T; Losada-Fernández I; Vargas JA; Jordá J; Alvarez N; García-Marco J; Pérez-Aciego P
Am J Clin Pathol; 2005 May; 123(5):646-50. PubMed ID: 15981803
[TBL] [Abstract][Full Text] [Related]
17. Variability of ZAP 70 expression in a patient with CLL.
Chaar BT; Grosso L; Petruska PJ
Am J Hematol; 2006 Aug; 81(8):645. PubMed ID: 16823829
[No Abstract] [Full Text] [Related]
18. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
[TBL] [Abstract][Full Text] [Related]
19. Is chronic lymphocytic leukemia one disease?
Dighiero G
Haematologica; 2002 Dec; 87(12):1233-5. PubMed ID: 12495892
[No Abstract] [Full Text] [Related]
20. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
Vargas RL; Felgar RE; Rothberg PG
J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
[No Abstract] [Full Text] [Related]
[Next] [New Search]